Show simple item record

 
dc.contributorVall d'Hebron Barcelona Hospital Campus
dc.contributor.authorFreixas Bermejo, Marta
dc.contributor.authorRiera Soler, Luis
dc.contributor.authorGarcía Martínez, Laura
dc.contributor.authorSegarra, Oscar
dc.date.accessioned2025-10-16T07:23:15Z
dc.date.available2025-10-16T07:23:15Z
dc.date.issued2025
dc.identifier.citationFreixas Bermejo M, Riera Soler L, García Martínez L, Segarra Cantón O. Recurrent Pneumothorax in a Pediatric Patient with Crohn’s Disease Receiving Ustekinumab Treatment: Case Report. Case Rep Gastroenterol. 2025;19(1):134-9.
dc.identifier.issn1662-0631
dc.identifier.urihttp://hdl.handle.net/11351/13875
dc.descriptionCrohn disease; Inflammatory bowel disease; Pneumothorax
dc.description.abstractIntroduction: We present the case of a patient with Crohn's disease who experienced recurrent pneumothorax after starting treatment with ustekinumab. Case presentation: A patient with Crohn's disease started an induction regimen with intravenous ustekinumab, and 2 months later he presented a left-sided pneumothorax. It had an atypical evolution that required surgical management. The medication was withdrawn and the pneumothorax resolved completely. One year later, he had a new flare-up of Crohn's disease and ustekinumab therapy was restarted, presenting a new episode of pneumothorax. Conclusion: To our knowledge, this is the first report of recurrent pneumothorax following two separate attempts to initiate ustekinumab.
dc.language.isoeng
dc.publisherKarger
dc.relation.ispartofseriesCase Reports in Gastroenterology;19(1)
dc.rightsAttribution-NonCommercial 4.0 International
dc.rights.urihttp://creativecommons.org/licenses/by-nc/4.0/
dc.sourceScientia
dc.subjectCrohn, Malaltia de - Tractament
dc.subjectAnticossos monoclonals - Ús terapèutic - Efectes secundaris
dc.subjectPneumotòrax
dc.subject.meshPneumothorax
dc.subject.meshCrohn Disease
dc.subject.mesh/drug therapy
dc.subject.meshAntibodies, Monoclonal
dc.subject.mesh/adverse effects
dc.titleRecurrent Pneumothorax in a Pediatric Patient with Crohn’s Disease Receiving Ustekinumab Treatment: Case Report
dc.typeinfo:eu-repo/semantics/article
dc.identifier.doi10.1159/000543991
dc.subject.decsneumotórax
dc.subject.decsenfermedad de Crohn
dc.subject.decs/farmacoterapia
dc.subject.decsanticuerpos monoclonales
dc.subject.decs/efectos adversos
dc.relation.publishversionhttps://doi.org/10.1159/000543991
dc.type.versioninfo:eu-repo/semantics/publishedVersion
dc.audienceProfessionals
dc.contributor.organismesInstitut Català de la Salut
dc.contributor.authoraffiliation[Freixas Bermejo M, Segarra Cantón O] Unitat de Gastroenterologia, Hepatologia, Suport Nutricional i Trasplantaments Hepàtics Pediàtrics, Vall d’Hebron Hospital Universitari, Barcelona, Spain. [Riera Soler L] Servei de Radiologia Pediàtrica, Vall d’Hebron Hospital Universitari, Barcelona, Spain. [García Martínez L] Servei de Cirurgia Pediàtrica, Vall d’Hebron Hospital Universitari, Barcelona, Spain
dc.identifier.pmid40880673
dc.identifier.wos001453990200001
dc.rights.accessrightsinfo:eu-repo/semantics/openAccess


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record